Medical Therapy to Prevent Recurrence of Disease after an Intervention. Efficacy or Lack of Efficacy

Severe hypertriglyceridemia associated with everolimus drug-eluting stent placement in an infant

Kuan-Chi Lai, Julie A. Brothers, Jason Z. Stoller Children’s Hospital of Philadelphia.United States Cardiology in the YoungCardiol Young 2019; 29: 541-543DOI: 10.1017/S1047951119000167 AbstractWe report a case of severe hypertriglyceridemia associated with an everolimus drug-eluting stent in an infant with pulmonary vein stenosis. We review from current literature the mechanisms by which everolimus may cause dyslipidaemia, pharmacokinetics […]

Severe hypertriglyceridemia associated with everolimus drug-eluting stent placement in an infant Read More »

New Paradigms for Pulmonary Vein Stenosis Treatment: When Surgery and Transcatheter Therapy Aren’t Good Enough

Usama B. Kanaan, William T. Mahle Children’s Healthcare of Atlanta and Emory University School of Medicine.United States Journal of PediatricsJ Pediatr 2018; 198: 12-13DOI: 10.1016/j.jpeds.2018.01.082 AbstractAbstract Not Available CategoryStenosis or Obstruction of Normal Pulmonary Venous ConnectionsStenosis or Obstruction of Pulmonary Veins Following Surgical Repair of Anomalous Pulmonary Venous ConnectionsMultidisciplinary CareMedical Therapy to Prevent or Reverse the

New Paradigms for Pulmonary Vein Stenosis Treatment: When Surgery and Transcatheter Therapy Aren’t Good Enough Read More »

Management of Pediatric Pulmonary Vein Stenosis

Ryan Callahan, Brian H. Morray, Russel Hirsch, Christopher J. Petit Boston Children’s Hospital and Harvard Medical School. Seattle Children’s Hospital and University of Washington School of Medicine. Cincinnati Children’s Hospital and University of Cincinnati College of Medicine. Morgan Stanley Children’s Hospital, NewYork-Presbyterian Hospital and Columbia University Vagelos College of Physicians and Surgeons.United States Journal for

Management of Pediatric Pulmonary Vein Stenosis Read More »

Novel Use of Drug-Coated Balloon Angioplasty to Treat Pulmonary Vein Stenosis

Saloni Agrawal, Kali A. Hopkins, Ali N. Zaidi, Barry Love Mount Sinai Hospital. Mount Sinai Fuster Heart Hospital.United States Journal of the American College of Cardiology Case ReportsJACC Case Rep 2024; 29:DOI: 10.1016/j.jaccas.2024.102613 AbstractPulmonary vein stenosis is challenging to treat due to high rate of recurrence. Multiple interventions exist but are limited by high rates of

Novel Use of Drug-Coated Balloon Angioplasty to Treat Pulmonary Vein Stenosis Read More »

Paclitaxel-coated drug-eluting balloon for pulmonary vein stenosis after repair of total anomalous pulmonary venous return with asplenia

Hiroshi Ono, Ryo Mafune, Taiyu Hayashi, Yasushi Misaki, Yukihiro Kaneko, Jumpei Saito, Miki Nagai, Hitoshi Kato National Medical Center for Child Health and Development.Japan Journal of Cardiology CasesJ Cardiol Cases 2020; 22: 107-109DOI: 10.1016/j.jccase.2020.05.008 AbstractWe used a paclitaxel-coated drug-eluting balloon (DEB) for pulmonary vein stenosis (PVS) after repair of total anomalous pulmonary venous return with asplenia.

Paclitaxel-coated drug-eluting balloon for pulmonary vein stenosis after repair of total anomalous pulmonary venous return with asplenia Read More »

Paclitaxel drug-eluting stent placement for pulmonary vein stenosis as a bridge to heart-lung transplantation

Andreea Dragulescu, Olivier Ghez, Jacques Quilici, Alain Fraisse Centre Hospitalo-Universitaire La Timone.France Pediatric CardiologyPediatr Cardiol 2009; 30: 1169-1171DOI: 10.1007/s00246-009-9511-5 AbstractCongenital pulmonary vein stenosis (PVS) presents as an isolated lesion or in association with other congenital heart anomalies. The most extensive forms of the disease are uniformly fatal because neither surgical repair nor transcatheter therapy results in

Paclitaxel drug-eluting stent placement for pulmonary vein stenosis as a bridge to heart-lung transplantation Read More »

Valsartan to Prevent Acquired Pulmonary Vein Stenosis in Pediatric Patients After Total Anomalous Pulmonary Venous Connection Surgery

Jin Shentu, Mingjie Zhang, Zhuoming Xu, Chen Wen, Hao Zhang, Zhongqun Zhu, Huiwen Chen, Guocheng Shi Shanghai Children’s Medical Center and Shanghai Jiao Tong University.China Journal of the American Heart AssociationJ Am Heart Assoc 2025; 14:DOI: 10.1161/JAHA.124.036911 AbstractBackground: Recurrent pulmonary vein stenosis (PVS) following surgical repair of total anomalous pulmonary venous connection is associated with poor prognosis. Preclinical studies have shown that use of an angiotensin receptor blocker can attenuate intimal hyperplasia;

Valsartan to Prevent Acquired Pulmonary Vein Stenosis in Pediatric Patients After Total Anomalous Pulmonary Venous Connection Surgery Read More »

Systemic Sirolimus Therapy Is Associated With Reduced Intervention Frequency in Pulmonary Vein Stenosis

Alyssa B. Kalustian, Joseph L. Hagan, Paige E. Brlecic, Ionela Iacobas, Rachel D. Vanderlaan, Joseph Burns, Thao T. Wu, Ravi Birla, Sharada Gowda, Manish Bansal, Srinath T. Gowda, Lindsay F. Eilers, Asra Khan, Juan Pablo Sandoval-Jones, Michiaki Imamura, Yishay Orr, Christopher A. Caldarone, Athar M. Qureshi Texas Children’s Hospital and Baylor College of Medicine. Hospital

Systemic Sirolimus Therapy Is Associated With Reduced Intervention Frequency in Pulmonary Vein Stenosis Read More »

Targeted Rapamycin Delivery via Magnetic Nanoparticles to Address Stenosis in a 3D Bioprinted in Vitro Model of Pulmonary Veins

Liqun Ning, Stefano Zanella, Martin M. Tomov, Medhi Salar Amoli, Linqi Jin, Bouen Hwang, Maher Saadeh, Huang Chen, Sunder Neelakantan, Lakshmi Prasad Dasi, Reza Avazmohammadi, Morteza Mahmooudi, Holly D. Bauser-Heaton, Vahid Serpooshan Emory University School of Medicine, Children’s Healthcare of Atlanta and Georgia Institute of Technology. Cleveland State University. Texas A&M University. Michigan State University.United

Targeted Rapamycin Delivery via Magnetic Nanoparticles to Address Stenosis in a 3D Bioprinted in Vitro Model of Pulmonary Veins Read More »

In Search of the Holy Grail for Pediatric Pulmonary Vein Stenosis

Lourdes R. Prieto Nicklaus Children’s Hospital.United States Journal of the American College of CardiologyJ Am Coll Cardiol 2021; 77: 2819-2821DOI: 10.1016/j.jacc.2021.04.029 AbstractAbstract Not Available CategoryMedical Therapy to Prevent or Reverse the Onset of Disease. Efficacy or Lack of EfficacyMedical Therapy to Prevent Progression of Disease. Efficacy or Lack of EfficacyMedical Therapy to Prevent Recurrence of Disease

In Search of the Holy Grail for Pediatric Pulmonary Vein Stenosis Read More »